Health Technology Assessment… Value, Affordability, and… Broader value and societal… The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region Read more
Cell and Gene Therapies Value, Affordability, and… Budget Impact Analysis Challenges and Solutions for Budget Impact Analysis of Gene Therapies Read more
Health Technology Assessment… Value, Affordability, and… Establishing the Economic Value of Carbon-Minimal Inhalers Read more
Drug Development/R&D Economics of Innovation Competition The Importance of Diversity of Supply in Rare Diseases Markets Read more © VK Studio at stock.adobe.com
Health Technology Assessment… Measuring and Valuing Outcomes Societal preferences Understanding societal preferences for priority by disease severity in England & Wales Read more
OHE Newsroom Comment, press releases and other news from OHE. News November 2024 Applications open for MSc Fellowship Programme 2025 Read more News January 2024 A switch to vegan diets could save the NHS £6.7 billion per year, new research reveals Read more Filter results by Topic Select the product option you would like to filter Topic Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Indication-Based Pricing Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing Date 1 Select the product option you would like to filter Date Clear Filter Date From Month From Year From Date To Month To Year To January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 January February March April May June July August September October November December total + el.scrollHeight*2, 0) + 'px'" > Today - 2020 2020 2021 2022 2023 2024 2025 2019 - 2010 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2009 - 2000 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 1999 - 1990 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1989 - 1980 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1979 - 1970 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1969 - 1960 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 Reset Filters News April 2019 Can We Really Compare and Aggregate Patient-reported Outcomes Between People and Settings? Read more News April 2019 The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment Read more News April 2019 Quality of Life and Rare Disease: Lessons from Spinal Muscular Atrophy Read more News March 2019 Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot Read more News March 2019 Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast… Read more News March 2019 OHE Lunchtime Seminar: Cascades of Care in Health Policy Analysis and Planning Read more News March 2019 Is Rate Of Return Pricing A Useful Approach When Value-Based Pricing Is Not Appropriate? Read more News March 2019 Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England Read more News March 2019 Abolishing Pharmaceutical Rebates in the US? Looking at the Trade-Offs Read more News March 2019 Cheap and Dirty: The Effect of Contracting Out Cleaning on Efficiency and Effectiveness Read more News March 2019 The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback Read more News February 2019 Pricing and Paying for Cures: Early Experience with HTA of Gene Therapy in the USA Read more 00 04 05 06 07 08 09 10 11 12 00 Subscribe To Our Newsletter Our monthly Bulletin highlights our work alongside the latest from across health economics and health care. Sign Up Now
News January 2024 A switch to vegan diets could save the NHS £6.7 billion per year, new research reveals Read more
News April 2019 Can We Really Compare and Aggregate Patient-reported Outcomes Between People and Settings? Read more
News April 2019 The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment Read more
News March 2019 Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot Read more
News March 2019 Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Not So Fast… Read more
News March 2019 OHE Lunchtime Seminar: Cascades of Care in Health Policy Analysis and Planning Read more
News March 2019 Is Rate Of Return Pricing A Useful Approach When Value-Based Pricing Is Not Appropriate? Read more
News March 2019 Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England Read more
News March 2019 Cheap and Dirty: The Effect of Contracting Out Cleaning on Efficiency and Effectiveness Read more
News March 2019 The World Needs Better Drugs for TB. The Center for Global Development and OHE Have a Proposal and We Need your Feedback Read more
News February 2019 Pricing and Paying for Cures: Early Experience with HTA of Gene Therapy in the USA Read more